Biomarin Pharmaceutical (BMRN) Q3 2018 Earnings

2AugConfirmed
Q4 2017
Q1 2018
Q2 2018
Q3 2018
-0.4
-0.29
-0.18
-0.07

Details

Expected EPS
-0.14
Actual EPS
-0.21
Surprise EPS
-0.07
Surprise Percent
+50%

Description

Biomarin Pharmaceutical (BMRN) has reported earnings of -0.21 per share for Q3 2018.

0 Comments

Share your thoughts